scholarly article | Q13442814 |
P356 | DOI | 10.1177/0269881109106953 |
P698 | PubMed publication ID | 19939870 |
P2093 | author name string | Gary Evoniuk | |
Jack G Modell | |||
Alok Krishen | |||
Alfred Le Clus | |||
Hans-Peter Wunderlich | |||
Karen Hewett | |||
Michelle D Gee | |||
P2860 | cites work | 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL | Q24530904 |
A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor | Q24563250 | ||
A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline | Q28377576 | ||
Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment | Q28377591 | ||
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. | Q33994367 | ||
Efficacy of venlafaxine in geriatric depression | Q34093713 | ||
Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients | Q34454456 | ||
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability | Q34566285 | ||
Depression in late life: review and commentary | Q35084435 | ||
The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database | Q41093446 | ||
A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine | Q43717721 | ||
Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health | Q44253289 | ||
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression | Q45251035 | ||
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. | Q46477533 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | placebo | Q269829 |
P304 | page(s) | 1209-1216 | |
P577 | publication date | 2009-11-25 | |
P1433 | published in | Journal of Psychopharmacology | Q6295819 |
P1476 | title | Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. | |
P478 | volume | 24 |
Q48868283 | A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders |
Q21144599 | Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes |
Q26747727 | Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant |
Q37810766 | Drug treatment for mood disorders in pregnancy |
Q37309556 | Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder |
Q26864531 | Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine |
Q57820341 | Gebelikte Psikotrop İlaç Kullanımı: Bir Güncelleme |
Q37503551 | Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout |
Q46182025 | Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants |
Q39402042 | Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone). |
Q90295943 | Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers |
Q38714376 | Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity |
Q34240696 | Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review |
Q38817431 | The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Q37694366 | The effect of vortioxetine on overall patient functioning in patients with major depressive disorder |
Q34226014 | The efficacy and tolerability of bupropion in the treatment of major depressive disorder |
Q28300843 | The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects |
Search more.